Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 03, 2023, titled "Alembic Pharmaceuticals receives various US Food & Drug Administration (USFDA) (Tentative or Final) product approvals during the quarter ended 30th June, 2023.".